Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
SWKH, SWKHL | SWK Holdings Corp | Director | $111K | Dec 30, 2022 | ||
EYPT | EyePoint Pharmaceuticals, Inc. | Director | $77.6K | +$20K | +34.7% | Aug 20, 2024 |
AKTX | Akari Therapeutics Plc | Interim CFO | May 1, 2024 | |||
RCOR | Renovacor, Inc. | Chief Financial Officer | Dec 1, 2022 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|